Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25434306 | 0.82 | CA1 (0.61) | SMN1; SMN2CA12CA1CA2CA14 | |
| SCHEMBL151213 | 0.82 | CA1 (0.61) | SMN1; SMN2CA12CA1CA2CA14 | |
| SCHEMBL27753904 | 0.82 | CA1 (0.61) | SMN1; SMN2CA12CA1CA2CA14 | |
| SCHEMBL5540145 | 0.81 | CA1 (0.44) | SMN1; SMN2CA12CA1CA2CA14 | |
| SCHEMBL16953346 | 0.81 | NPSR1 (0.41) | SMN1; SMN2CA12CA1CA2CA14 | |
| SCHEMBL10980213 | 0.81 | SMN1; SMN2 (0.52) | SMN1; SMN2CA12CA1CA2CA14 | |
| SCHEMBL10981497 | 0.81 | ALDH1A1 (0.42) | SMN1; SMN2KDM4EALDH1A1LMNAMAPT | |
| SCHEMBL5534722 | 0.80 | CA1 (0.48) | SMN1; SMN2CA12CA1CA2CA14 | |
| Formaldehyde SCHEMBL28092618 | 0.80 | SMN1; SMN2 (0.54) | SMN1; SMN2CA12CA1CA2CA14 | |
| SCHEMBL16960162 | 0.80 | HPGD (0.34) | SMN1; SMN2CA12CA1CA2CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4244 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024094607-A1 | ISOTOPE LABELED AND NON-LABELED GENTAMICIN C CONGENERS | ROCHE DIAGNOSTICS GMBH (DE) | 2024-05-10 | — | — | WO | claimed |
| CN-117486966-A | Method for synthesizing brassinolide | 山东成武泽大泛科化工有限公司 | 2024-02-02 | — | — | CN | claimed |
| WO-2024010870-A2 | CRYSTALLINE MONOMERS FOR PREPARING ANTISENSE OLIGONUCLEOTIDES AND METHODS OF THEIR PREPARATION AND USE | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2024-01-11 | — | — | WO | claimed |
| EP-4272000-A2 | LINKER STRUCTURES WITH MINIMAL SCAR FOR ENZYMATIC SYNTHESIS | Microsoft Technology Licensing LLC (US) | 2023-11-08 | — | — | EP | claimed |
| EP-3575281-B1 | DIAMINE COMPOUND, AND POLYIMIDE COMPOUND AND MOLDED ARTICLE IN WHICH SAID DIAMINE COMPOUND IS USED | WINGO TECH CO LTD (JP) | 2023-08-23 | — | — | EP | claimed |
| WO-2023150653-A1 | PROCESS FOR SYNTHESIS OF QUINAZOLINE COMPOUNDS | GENENTECH, INC. (US) | 2023-08-10 | — | — | WO | claimed |
| US-20230250074-A1 | PROCESS FOR SYNTHESIS OF QUINAZOLINE COMPOUNDS | GENENTECH, INC. (US) | 2023-08-10 | — | — | US | claimed |
| EP-4196470-A1 | SYNTHESIS OF QUINAZOLINE COMPOUNDS | Genentech, Inc. (US) | 2023-06-21 | — | — | EP | claimed |
| US-20230151047-A1 | LINKER STRUCTURES WITH MINIMAL SCAR FOR ENZYMATIC SYNTHESIS | MICROSOFT TECHNOLOGY LICENSING, LLC | 2023-05-18 | — | — | US | claimed |
| EP-4178959-A1 | NITROGEN HETEROCYCLIC CYTOKININ DERIVATIVES, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF | Univerzita Palackého v Olomouci (CZ) | 2023-05-17 | — | — | EP | claimed |
| US-4520193-A | Cephalosporin derivatives | RHONE-POULENC INDUSTRIES (FR) | 1985-05-28 | — | — | US | claimed |
| EP-0093010-A2 | Alpha-hydroxyethylphosphinates, and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-11-02 | — | — | EP | claimed |
| EP-0053540-A1 | Cephalosporin derivatives and their preparation | RHONE-POULENC SANTE (FR) | 1982-06-09 | — | — | EP | claimed |
| US-4235906-A | MUSCLE RELAXANTS | MASSACHUSETTS GENERAL HOSPITAL (US) | 1980-11-25 | — | — | US | claimed |
| US-4232014-A | AMIDOALKYLINDANS | MARION LABORATORIES, INC. (US) | 1980-11-04 | — | — | US | claimed |
| US-4206213-A | IMPROVING PERIPHERAL AND CEREBRAL CIRCULATION | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1980-06-03 | — | — | US | claimed |
| US-4159267-A | Novel silyl ester azetidine-2-sulfenate intermediates and process for preparing desacetoxycephalosporins | ELI LILLY AND COMPANY (US) | 1979-06-26 | — | — | US | claimed |
| US-4145538-A | 3-Carbamyloxymethyl-cephalosporins | ELI LILLY AND COMPANY (US) | 1979-03-20 | — | — | US | claimed |
| US-3993643-A | ANTISCHISTOSOMAL | STANFORD RESEARCH INSTITUTE (US) | 1976-11-23 | — | — | US | claimed |
| US-3944545-A | Process for preparing desacetoxycephalosporins | ELI LILLY AND COMPANY (US) | 1976-03-16 | — | — | US | claimed |